Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-12

FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's supplemental application for Buprenorphine Hydrochloride, updating the approved product's labeling and/or specifications. This is a suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine Hydrochloride (Buprenorphine hydrochloride)

Snippet

SUPPL AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)